St Onge EL, Miller SA (2010) Albiglutide: a new GLP-1 analog for the treatment of type 2 diabetes
The peptide stimulates expression of early growth response 1 (EGR-1) gene, which regulates cytokine and growth factor generation along with early extracellular matrix formation, while simultaneously inducing its repressor NAB2 to prevent excessive angiogenic signaling
A 100C LiPo battery strikes the perfect balance between power, weight, and reliability
Exercise Reducing exposure to environmental toxins, such as pollution and tobacco smoke, can help maintain healthy glutathione levels
Adverse Reactions (6.1).] Sitagliptin Add-on Therapy in Patients with Type 2 Diabetes Inadequately Controlled on the Combination of Metformin and Rosiglitazone A total of 278 patients with type 2 diabetes participated in a 54-week, randomized, double-blind, placebo-controlled study designed to assess the efficacy of sitagliptin in combination with metformin and rosiglitazone
Constant support provides advice on eating habits, day-to-day activities, and exercise routines